Template:CCI Guideline Vasoactive Drugs TISS: Revision history

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

1 August 2024

15 May 2024

9 May 2024

16 March 2022

  • curprev 15:2715:27, 16 March 2022 Ttenbergen talk contribs m 935 bytes +294 No edit summary
  • curprev 15:2515:25, 16 March 2022 Ttenbergen talk contribs 641 bytes +641 Created page with "Both {{TISS w Nr | Vasoactive drug IV continuous-multiple simultaneous (TISS Item)}} and {{TISS w Nr | Vasoactive drug IV continuous-multiple simultaneous (TISS Item)}}: * do '''not include pure antiarrhythmics''' -- by which we mean agents that might not ALSO be used for cardiotonic effects (such as iv beta blockers) * include all vasoactive and cardio-active agents, including: **Catecholamines: norepinephrine, epinephrine, phenylephrine, dopamine **Other vasoconstri..."